Yohei Sagawa Selected Research

Antibodies

4/2011

The pathophysiologic basis of secondary narcolepsy and hypersomnia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yohei Sagawa Research Topics

Disease

9	Narcolepsy 12/2018 - 01/2010
6	Cataplexy 12/2018 - 01/2010
5	Disorders of Excessive Somnolence (Hypersomnia) 12/2018 - 04/2011
4	Idiopathic Hypersomnia 10/2021 - 01/2015
3	Sleepiness 01/2018 - 01/2010
1	Apnea 01/2018
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2018
1	Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome) 01/2018
1	Obesity 05/2016
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 05/2016
1	Sleep Wake Disorders 02/2015
1	Sleep Deprivation 11/2014
1	Body Weight (Weight, Body) 11/2011
1	Neuromyelitis Optica (Devic's Disease) 04/2011
1	Nervous System Diseases (Neurological Disorders) 04/2011

Drug/Important Bio-Agent (IBA)

6	OrexinsIBA 01/2018 - 01/2010
3	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018 - 02/2015
3	HLA-DQB1 antigen (HLA DQB1)IBA 12/2018 - 01/2015
2	Aripiprazole (Abilify)FDA Link 10/2021 - 01/2018
2	Ataxin-3IBA 11/2016 - 11/2014
1	N 30IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 01/2018
1	Modafinil (Provigil)FDA Link 11/2016
1	CC ChemokinesIBA 10/2015
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2015
1	Ethanol (Ethyl Alcohol)IBA 11/2011
1	Aquaporin 4IBA 04/2011
1	AntibodiesIBA 04/2011
1	Immunoglobulin G (IgG)IBA 04/2011
1	LigandsIBA 01/2010
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2010
1	Orexin ReceptorsIBA 01/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2010
1	Peptides (Polypeptides)IBA 01/2010

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2018